Industry

— New Agreement Continues to Enable Rapid and Equitable Access to Veklury for COVID-19 Patients in EU and EEA Countries — FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences and the European Commission today signed a new joint procurement agreement (JPA) that will ensure continued rapid and equitable access to Veklury® (remdesivir) for participating Member States across the … [Read more…]

DURHAM, N.C.–(BUSINESS WIRE)–After a 14-year partnership at Duke University, Family Connects International (FCI) has launched as an independent nonprofit. The transition from a home nurse-visiting pilot initiative to a nonprofit enables it to expand services to reach more families with newborns and to provide a higher level of support to community partners across the U.S. … [Read more…]

Phase 3 clinical trial data in patients post-bunionectomy demonstrated SEGLENTIS as an efficacious and well-tolerated multimodal treatment option for appropriate adult patients with acute pain. MONTGOMERY, Ala.–(BUSINESS WIRE)–Kowa Pharmaceuticals America, Inc. announced the publication of Phase 3 clinical trial results in Pain Practice reinforcing that SEGLENTIS® a unique co-crystal combination of celecoxib 56-mg and tramadol … [Read more…]

Testing available at no out-of-pocket cost for qualified insured individuals at Rite Aid drive-thru locations with appointment; at all other Rite Aid locations customers can schedule to pick up at-home specimen collection kits for PCR testing PHILADELPHIA & SECAUCUS, N.J.–(BUSINESS WIRE)–Rite Aid (NYSE: RAD) today announced it is collaborating with Quest Diagnostics (NYSE: DGX) to … [Read more…]

Largest study of RhinAer to date shows 87% of patients reported quality-of-life improvements SUNNYVALE, Calif.–(BUSINESS WIRE)–#ENT—Aerin Medical Inc., a company that provides Ear, Nose and Throat (ENT) physicians with non-invasive solutions to treat chronic nasal conditions, today announced the publication of positive results from the RELIEF clinical trial in the American Journal of Rhinology & … [Read more…]

For future pandemics, we will build on the achievements which led to developing and scaling up multiple safe and effective vaccines and innovative treatments against COVID-19 in historic record time, collaborating with partners all over the world and executing on access plans. The innovative biopharmaceutical industry applauds the G7’s commitment to strengthening global pandemic preparedness … [Read more…]

TORONTO–(BUSINESS WIRE)–(TSX: LWRK) LifeWorks Inc. (the “Company” or “LifeWorks”) announced today a cash dividend of $0.065 per share for the month of July 2022, to be paid on August 15, 2022 to holders of record of shares of LWRK on July 29, 2022. LifeWorks designates this dividend to be an “eligible dividend” pursuant to subsection … [Read more…]

ROCKVILLE, Md.–(BUSINESS WIRE)–Creative Bio-Peptides, Inc, a preclinical-stage biotechnology company developing novel therapies to balance the innate immune system and promote regeneration of damaged neurons, today announced the publication of findings from a preclinical study showing that treatment with the multi-chemokine receptor antagonist oral peptide RAP-103 substantially reduced heroin self-administration and motivation to consume heroin. RAP-103 … [Read more…]

MINNEAPOLIS–(BUSINESS WIRE)–Agiliti Inc. (NYSE: AGTI) (“Agiliti”) today announced that the company will release its second quarter results after the market close on Tuesday, August 9, 2022, to be followed by a conference call at 5 p.m. Eastern Time on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0792 … [Read more…]

NEW YORK–(BUSINESS WIRE)–#BoardofDirectors—Koneksa, a healthcare technology company pioneering digital biomarkers, today announced the appointment of Maria C. Freire, Ph.D., to its Board of Directors. Dr. Freire is an accomplished executive and public health leader with a proven track record in enabling life sciences companies to maximize the potential of their technology platforms. “Koneksa is privileged … [Read more…]